Midkine release during hemodialysis is predictive of hypervolemia and associates with excess (cardiovascular) mortality in patients with end-stage renal disease: a prospective study

BACKGROUND: In end-stage renal disease, a high cardiovascular risk profile and endothelial damage prevails. The heparin-binding growth factor midkine stimulates neo-angiogenesis in ischemic diseases, coordinates neutrophil influx, and raises blood pressure through stimulated angiotensin synthesis. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandt, Sabine, Fischer, Anja, Kreutze, Carla, Hempel, Dorothea, Gorny, Xenia, Scurt, Florian G., Şalaru, Delia L., Bartsch, Peter, Bernhardt, Anja, Bode-Böger, Stefanie M., Girndt, Matthias, Fiedler, Roman, Isermann, Berend, Lindquist, Jonathan A., Mertens, Peter R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Nephrology - Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372127/
https://www.ncbi.nlm.nih.gov/pubmed/35211826
http://dx.doi.org/10.1007/s11255-022-03141-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372127/
https://www.ncbi.nlm.nih.gov/pubmed/35211826
http://dx.doi.org/10.1007/s11255-022-03141-4

Ejemplares similares